Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Clinical Endocrinology|September 10, 2004
Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injuryGianluca Aimaretti, Maria Rosaria Ambrosio, Carolina Di Somma, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Long-term follow-up in adrenal incidentalomas: an Italian multicenter studyValentina Morelli, Giuseppe Reimondo, Roberta Giordano, et al.
European Journal of Endocrinology|July 25, 2009
Effects of acute administration of acylated and unacylated ghrelin on glucose and insulin concentrations in morbidly obese subjects without overt diabetesRosalie M Kiewiet, Maarten O van Aken, Kim van der Weerd, et al.
Biomedicines|April 23, 2022
Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 PneumoniaLorenzo Marinelli, Guglielmo Beccuti, Marco Zavattaro, et al.
European Journal of Endocrinology|April 1, 2022
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgeryMirko Parasiliti-Caprino, Fabio Bioletto, Chiara Lopez, et al.
International Journal of Molecular Sciences|April 17, 2025
Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer CellsIacopo Gesmundo, Francesca Pedrolli, Francesca Romana Giglioli, et al.
Pituitary|September 10, 2017
Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegalyAart J van der Lely, Roy Gomez, Andreas Pleil, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 7, 2023
Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT IntervalDiane M Donegan, Rosario Pivonello, Antonio Stigliano, et al.
The Journal of Cell Biology|December 18, 2002
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKTGianluca Baldanzi, Nicoletta Filigheddu, Santina Cutrupi, et al.
Pageof 30